Several clinical reports have highlighted the prognostic importance of TGF-β1 in a variety of tumours, including NSCLC, suggesting that circulating plasma levels are correlated with the extent of disease and disease recurrence [35], [66], [67], [68], [69]. Here, TGFB1 is linked to non-small cell lung carcinoma.